BTK and lymphoma: For example, in mantle cell lymphoma (MCL), lymphoma cells reprogram metabolically toward OXPHOS and glutaminolysis to gain advantage in generating energy and develop drug resistance to Bruton’s tyrosine kinase (BTK) inhibitors (9).